9LP-16741-86509
4 vaccinations
2 coded responses
20 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Dose 1 — Pfizer-BioNTech
-
2020-12-28
Registered in v-safe
- 2020-12-30
- 2020-12-31
- 2021-01-07
-
2021-01-10
Dose 2 — Pfizer-BioNTech
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-24
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-04-11
- 2021-07-13
-
2021-08-30
Dose 3 — Pfizer-BioNTech
-
2022-01-10
Survey response — 12 months, dose 2MedDRA: Cough, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat. Cough. Tested negative for covid.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-22
Dose 4 — Pfizer-BioNTech
-
2022-11-01
Survey response — day 35, dose 4MedDRA: Alanine aminotransferase increased, Blood alkaline phosphatase increased, Brain fog, Double stranded DNA antibody positive, Fatigue, Infection, Red blood cell sedimentation rate increased, Smooth muscle antibody positive — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Frequent infections, fatigue, brain fog, elevated ALT and all phos, elevated ESR, positive anti ds DNA and anti smooth muscle antibodies- being evaluated furtherMedDRA releases: 2024-11 · check-in free text available
-
2022-11-01
Report sent to call center — day 35, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech | |
| 3 | 2021-08-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 10 — 12 months, dose 2
Symptoms: Sore throat. Cough. Tested negative for covid.
Release 12 — day 35, dose 4
Symptoms: Frequent infections, fatigue, brain fog, elevated ALT and all phos, elevated ESR, positive anti ds DNA and anti smooth muscle antibodies- being evaluated further
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alanine aminotransferase increased | · | · | ✓ |
| SD | Blood alkaline phosphatase increased | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Double stranded DNA antibody positive | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Infection | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Red blood cell sedimentation rate increased | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Smooth muscle antibody positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release